✦ LIBER ✦

Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life

✍ Scribed by Naohisa Kawamura; Yasunobu Tokoeda; Miho Oshima; Hiroyasu Okahata; Hiroyuki Tsutsumi; Leen Jan Van Doorn; Hisao Muto; Igor Smolenov; P.V. Suryakiran; Htay Htay Han

Book ID: 116963844
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 763 KB
Volume: 29
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2011.05.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human Rotavirus Vaccine RIX4414 (Rotarix

Human Rotavirus Vaccine RIX4414 (Rotarix™) Is Highly Efficacious in Infants from Asia During the First Two Years of Life

✍ K.B. Phua; F.S. Lim; Y.L. Lau; E.A.S. Nelson; L.M. Huang; S.H. Quak; B.W. Lee; Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Immunogenicity, reactogenicity and safet

Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants

✍ T. Vesikari; A. Karvonen; A. Bouckenooghe; P.V. Suryakiran; I. Smolenov; H.H. Ha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 627 KB

Rotavirus vaccine RIX4414 efficacy susta

Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: A randomized clinical trial in an Asian population

✍ Kong Boo Phua; Fong Seng Lim; Yu Lung Lau; Edmund Anthony Severn Nelson; Li Min 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 361 KB

Efficacy, safety and immunogenicity of a

Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial

✍ Lau, Yu-Lung; Nelson, E. Anthony S.; Poon, Kin-Hung; Chan, Paul K.S.; Chiu, Susa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Immunogenicity, Reactogenicity and Safet

Immunogenicity, Reactogenicity and Safety of the Oral Live Attenuated Human Rotavirus Vaccine RIX4414(Rotarix™) Oral Suspension (Liquid Formulation) in Vietnamese Infants

✍ D.D. Anh; V.D. Thiem; Y. Hutagalung; H.L. Bock; P. Suryakiran; A. Delem; H.H. Ha 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A short report on the highlights of worl

A short report on the highlights of world-wide development of RIX4414: a North American experience: Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine (RIX4414) in infants in the United States and Canada

✍ Penelope H. Dennehy 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 84 KB